NARDON, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 2.323
EU - Europa 2.001
AS - Asia 1.544
SA - Sud America 313
AF - Africa 56
OC - Oceania 10
Totale 6.247
Nazione #
US - Stati Uniti d'America 2.251
RU - Federazione Russa 959
SG - Singapore 666
CN - Cina 306
BR - Brasile 249
FR - Francia 215
IE - Irlanda 197
IT - Italia 171
HK - Hong Kong 165
VN - Vietnam 165
SE - Svezia 139
DE - Germania 120
GB - Regno Unito 82
KR - Corea 66
CA - Canada 44
FI - Finlandia 31
IN - India 29
BD - Bangladesh 26
AR - Argentina 25
MX - Messico 17
ID - Indonesia 16
JP - Giappone 16
PL - Polonia 15
ZA - Sudafrica 14
EC - Ecuador 13
TR - Turchia 13
IR - Iran 12
BE - Belgio 11
AT - Austria 10
CO - Colombia 10
ES - Italia 10
IQ - Iraq 10
NL - Olanda 10
AU - Australia 8
LT - Lituania 8
NG - Nigeria 8
PK - Pakistan 7
TG - Togo 7
BJ - Benin 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
UZ - Uzbekistan 5
CI - Costa d'Avorio 4
IL - Israele 4
MY - Malesia 4
PH - Filippine 4
PY - Paraguay 4
AL - Albania 3
KG - Kirghizistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
UA - Ucraina 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AS - Samoa Americane 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
Totale 6.247
Città #
Dallas 394
Chandler 318
Moscow 318
Singapore 297
Ashburn 274
San Jose 250
Dublin 192
Hong Kong 164
Verona 108
New York 75
Beijing 74
Lawrence 60
Princeton 60
Ho Chi Minh City 57
Los Angeles 54
Sindelfingen 51
The Dalles 50
Kent 48
Munich 36
Buffalo 31
Hanoi 29
São Paulo 27
Southend 26
Orem 22
Redondo Beach 22
Santa Clara 21
Boardman 17
Council Bluffs 16
Montreal 16
San Francisco 16
Tokyo 16
Toronto 16
Chennai 15
Da Nang 15
Denver 13
Frankfurt am Main 12
Helsinki 12
Warsaw 12
Johannesburg 11
Brussels 10
Lappeenranta 10
London 10
Stockholm 10
Atlanta 9
Leawood 9
Sacramento 9
Turku 9
Belo Horizonte 8
Mexico City 8
Poplar 8
West Jordan 8
Amsterdam 7
Ankara 7
Brooklyn 7
Houston 7
Jakarta 7
Lomé 7
Ninh Bình 7
Phoenix 7
Strasbourg 7
Biên Hòa 6
Campinas 6
Chicago 6
Columbus 6
Cotonou 6
Lagos 6
Nuremberg 6
Rio de Janeiro 6
São Bernardo do Campo 6
Thái Nguyên 6
Tianjin 6
Zanjan 6
Andover 5
Barnet 5
Manchester 5
Meda 5
Romola 5
Tashkent 5
Abidjan 4
Baghdad 4
Buenos Aires 4
Curitiba 4
Dhaka 4
Falkenstein 4
Fortaleza 4
Guarulhos 4
Hải Dương 4
Quito 4
Salvador 4
Seattle 4
Thái Bình 4
Asunción 3
Augusta 3
Bishkek 3
Cambiago 3
Canberra 3
Caxias do Sul 3
Haiphong 3
Hyderabad 3
Melbourne 3
Totale 3.597
Nome #
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga) 190
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu) 170
“Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” 163
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015 149
Ln(III) Complexes Embedded in Biocompatible PLGA Nanoparticles as Potential Vis-to-NIR Optical Probes 148
Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” n° domanda:102016000122377, brevetto per invenzione industriale (antiflogistic), 145
Near Infared Circularly Polarized Luminescence from water stable organic nanoparticles containing a chiral Yb(III) complex 145
Circularly Polarized Luminescence from New Heteroleptic Eu(III) and Tb(III) Complexes 140
Beyond Platinums: Gold Complexes as Anticancer Agents 140
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials 130
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties 129
CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy 127
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 126
Cellular and Computational Studies of Proteasome Inhibition and Apoptosis Induction in Human Cancer Cells by Amino Acid Schiff Base-Copper Complexes 126
DESIGN AND DEVELOPMENT OF NEW METAL-BASED BIOSENSORS FOR THE EARLY DETECTION OF CANCER ANTIGENS IN ONCOLOGY 126
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 124
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity 124
Editorial: Unravelling Copper-Regulatory Systems and Copper-Affected Pathways in Cancer Cells to Improve Current Therapies 119
20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography 119
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 117
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics 116
CCK8 receptor-mediated cancer treatment strategies in target therapy 116
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations 115
A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies 114
Cutting-Edge Nanosystems for Biomedical Applications 110
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 110
Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters 108
Gold complexes for therapeutic purposes: An updated Patent review (2010-2015) 105
Novel inorganic chemotherapeutics for cancer treatment 100
Effect of the Heteroaromatic Antenna on the Binding of Chiral Eu(III) Complexes to Bovine Serum Albumin 98
Promising Anticancer Mono- and Dinuclear Ruthenium(III) Dithiocarbamato Complexes: Systematic Solution Studies 93
In vitro and in vivo anticancer activity of recently patented gold-based peptidomimetics targeting peptide transporters 90
NIR-emission from Yb(III)- and Nd(III)-based complexes in the solid state sensitized by a ligand system absorbing in a broad UV and visible spectral window 88
Gold-based peptidomimetics for a targeted anticancer therapy 88
Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes 87
Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology 83
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 82
From cisplatin to world-shattering gold(III) anticancer agents 81
Lanthanide‐Based Complexes Containing a Chiral trans‐1,2‐Diaminocyclohexane (DACH) Backbone: Spectroscopic Properties and Potential Applications 80
Ubiquitin-Proteasome System impairment by the Gold(III) complex derivative AuL12 79
Design and Development of new metal-based biosensors for the early detection of cancer antigens in oncology 77
Noble metal-dithiocarbamates: precious allies in the fight against cancer 75
New metal-based cancer-targeting chemotherapeutics 75
Gold(III) complexes sensitize mitochondria of tumor cells to permeability transition 75
Throwing light on recent advances on metallodrugs: From deemed poisons to a striking hope for the future 70
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics 69
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts 69
New insights into the mechanism of action of the gold(III) dithiocarbamato complex AuL12: upstream inhibition of the ubiquitin-proteasome pathway and encapsulation in natural polysaccharides 69
New lanthanide-based biosensors for the early detection of cancer antigens 69
Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents 68
null 66
Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides 66
Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future 65
Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies 64
Gold(III) Complexes in the Oncological Preclinical Arena: from Aminoderivatives to Peptidomimetics 64
Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future 64
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology? 63
Gold(III) dithiocarbamate complexes induce cell death triggered by thioredoxin redox system inhibition, mitochondrial permeability increase, and activation of ERK pathway 62
Metal-based dithiocarbamato anticancer agents: an overview 61
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia 60
Leading-edge gold(III) targeted chemotherapeutics in translational oncology 59
New metal-based cancer-targeting chemotherapeutics 57
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 52
null 48
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells 38
null 12
Exploring the effect of copper on the bioactivity of 8-quinolines: an in vitro and in vivo study 4
Totale 6.321
Categoria #
all - tutte 24.916
article - articoli 13.961
book - libri 0
conference - conferenze 8.149
curatela - curatele 0
other - altro 0
patent - brevetti 2.057
selected - selezionate 0
volume - volumi 749
Totale 49.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022279 0 0 0 0 0 0 0 0 24 57 64 134
2022/2023967 87 117 90 177 54 242 1 55 116 5 13 10
2023/2024570 16 43 62 65 42 89 72 9 2 12 104 54
2024/20251.076 44 92 45 191 28 36 22 80 80 128 66 264
2025/20263.429 247 455 190 639 823 176 222 186 236 167 48 40
Totale 6.321